Alpine Associates Management’s Celgene Corp CELG Stock Holding History

Alpine Associates Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,911,850	Closed	-$190M	–	74
2019 Q3	$190M	Buy	1,911,850 +273,000	+17%	+$25.9M	6.22%	2
2019 Q2	$151M	Sell	1,638,850 -503,150	-23%	-$47.8M	4.45%	6
2019 Q1	$202M	Buy	+2,142,000	New	+$187M	6.66%	2

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Alpine Associates Management's CELG Position: Q4 2019 in Review

Alpine Associates Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,911,850 shares — an estimated $190M sold.

Alpine Associates Management first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $202M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Alpine Associates Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Alpine Associates Management sold 1,911,850 Celgene Corp shares in Q4 2019, an estimated $190M.
Alpine Associates Management first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
Alpine Associates Management's Celgene Corp position peaked at $202M in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Alpine Associates Management's 13F filing for Q4 2019, filed 13 Feb 2020.